Literature DB >> 19893000

Differences between ischemic stroke subtypes in vascular outcomes support a distinct lacunar ischemic stroke arteriopathy: a prospective, hospital-based study.

Caroline A Jackson1, Aidan Hutchison, Martin S Dennis, Joanna M Wardlaw, Steff C Lewis, Cathie L M Sudlow.   

Abstract

BACKGROUND AND
PURPOSE: Whether and how the arterial pathology underlying lacunar ischemic stroke differs from the atherothrombotic processes causing most other ischemic strokes is still debated. Different risks of recurrent stroke and MI after lacunar versus nonlacunar ischemic stroke may support a distinct lacunar arteriopathy.
METHODS: We prospectively followed a hospital-based cohort of 809 first-ever ischemic stroke patients for 1 to 4 years. We compared risks of death, recurrent stroke, and MI in patients with lacunar versus nonlacunar stroke, and performed an updated meta-analysis of recurrent stroke subtype patterns.
RESULTS: During 1725 person-years of follow-up, 109 patients had a recurrent stroke and 31 had MI. All patients at baseline, and 93% with recurrent stroke, had brain imaging and more than half with recurrent stroke had diffusion-weighted MRI. Overall, there was no difference in recurrence risk after lacunar vs nonlacunar stroke, although there was a trend toward a lower recurrence risk in the early weeks after lacunar stroke. Lacunar recurrence was more likely after lacunar than nonlacunar stroke (OR, 6.5; 95% CI, 2.4-17.5; updated meta-analysis OR, 6.8; 95% CI, 4.2-11.2). MI risk was nonsignificantly lower after lacunar than nonlacunar stroke (rate ratio, 0.5; 95% CI, 0.2-1.1; rate ratio after excluding patients with previous ischemic heart disease: 0.3; 95% CI, 0.1-0.9).
CONCLUSIONS: Our finding of a trend toward a lower MI risk after lacunar vs nonlacunar stroke and confirmation of both a lower early recurrence risk after lacunar stroke and a tendency of recurrent stroke subtypes to "breed true" support the notion of a distinct nonatherothrombotic lacunar arteriopathy.

Entities:  

Mesh:

Year:  2009        PMID: 19893000     DOI: 10.1161/STROKEAHA.109.558221

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

Review 1.  Antiplatelet Therapy in Cerebral Small Vessel Disease.

Authors:  Danielle de Sa Bouasquevisque; Oscar R Benavente; Ashkan Shoamanesh
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

2.  Clinical manifestation of cancer related stroke: retrospective case-control study.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Kee Hong Park; Soon-Tae Lee; Kon Chu; Jae-Kyu Roh
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

3.  Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.

Authors:  Anetta Undas; Agnieszka Slowik; Matthew Gissel; Kenneth G Mann; Saulius Butenas
Journal:  Thromb Res       Date:  2011-08-04       Impact factor: 3.944

4.  Poststroke outcomes vary by pathogenic stroke subtype in the Atherosclerosis Risk in Communities Study.

Authors:  Sara B Jones; Souvik Sen; Kamakshi Lakshminarayan; Wayne D Rosamond
Journal:  Stroke       Date:  2013-05-16       Impact factor: 7.914

5.  Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.

Authors:  William Whiteley; Caroline Jackson; Steff Lewis; Gordon Lowe; Ann Rumley; Peter Sandercock; Joanna Wardlaw; Martin Dennis; Cathie Sudlow
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

6.  Lack of association of white matter lesions with ipsilateral carotid artery stenosis.

Authors:  Gillian M Potter; Fergus N Doubal; Caroline A Jackson; Cathie L M Sudlow; Martin S Dennis; Joanna M Wardlaw
Journal:  Cerebrovasc Dis       Date:  2012-03-14       Impact factor: 2.762

7.  Comparison of statistical and clinical predictions of functional outcome after ischemic stroke.

Authors:  Douglas D Thompson; Gordon D Murray; Cathie L M Sudlow; Martin Dennis; William N Whiteley
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

8.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden.

Authors:  Julie Staals; Stephen D J Makin; Fergus N Doubal; Martin S Dennis; Joanna M Wardlaw
Journal:  Neurology       Date:  2014-08-27       Impact factor: 9.910

Review 9.  Cerebral small vessel disease and renal function: systematic review and meta-analysis.

Authors:  Stephen D J Makin; F A B Cook; Martin S Dennis; Joanna M Wardlaw
Journal:  Cerebrovasc Dis       Date:  2014-12-24       Impact factor: 2.762

Review 10.  Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions.

Authors:  Philip M Bath; Joanna M Wardlaw
Journal:  Int J Stroke       Date:  2015-03-02       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.